The Latest Breaking News from Cronos Group

Thinking About Buying Stock In Pieris Pharmaceuticals, Baidu Or Cronos Group?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Benzinga · Feb 28, 2022

Cronos Group Earnings Preview

Cronos Group (NASDAQ:CRON) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that Cronos Group will report an earnings per share (EPS) of $-0.11.

Benzinga · Feb 28, 2022

Cronos Q3 Revenue Grows 79% YoY To $20.4M, Audit Committee Completes Evaluation

Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) announced its 2021 third-quarter business results, revealing net revenue of $20.4 million, compared to $11.4 million in the same period of 2020.

Benzinga · Feb 18, 2022